Replimune Group, Inc. (REPL) Misses Q3 EPS by 1c

Replimune Group, Inc. (NASDAQ: REPL) reported Q3 EPS of ($0.77), $0.01 worse than the analyst estimate of ($0.76).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Replimune (REPL) call put ratio 1 call to 1.3 puts with a focus on August options
• Telix Pharmaceuticals Ltd (TLX) PT Lowered to $22 at Citi
• Microsoft Replaces OpenAI, Anthropic With Own AI in Some Apps - Bloomberg